Bioceros is one of the world’s premier provider of services related to preclinical development of monoclonal antibodies. Besides generation of high-yield GMP-ready protein producing cell lines, Bioceros has a toolbox to modify product characteristics according to customer needs, and (bio-)analytics including mass spectrometry. Bioceros’ services are available on a modular basis, fully adjustable to clients’ requests. Together with the other divisions of the Polpharma Group, we can offer a completely integrated program from DNA to drug product.

We can provide our customers with world class development capabilities and a capacity for industrial-scale supply, enabling them to advance their medicinal product and help patients in need.

The people at Bioceros strongly believe that true and close collaboration speeds up selection and development of clients’ most viable drug candidates. The commitment of the company extends beyond just putting a high-yield stable cell line together.